CLEARED PAYMENT REQUIREDNo order is fulfilled before payment verification and order review

Illustrative chrome-paper vial, not inventory photography. Supplied label claims are not verified analytical results.

Comparative research set

BPC-157 + TB-500 Comparative Research Set

KCC-SET-BT

BPC-157 + TB-500 · 10 mg

Set contents: BPC-157 + TB-500

Composition-based set for qualified comparative laboratory research; component identity and lot documentation are required before release.

Release status Coming soon

Coming soon

Catalog priceComing soon
Before you order

Current payment methods: PayPal · Cash App · Zelle

Shipping is limited to eligible U.S. destinations. Shipping and applicable tax are calculated after you enter your address and select delivery, before you pay. Payment and order details must be verified before fulfillment; carrier delivery times are separate.

Images are packaging concepts, not photographs of actual inventory or evidence of a lot’s documentation.

Shipping policy → · Returns & claims policy → · Need help? →

For laboratory research use only. Not for human or veterinary use.

KCC-SET-BT · PRE-LAUNCHBPC-157 + TB-500 · 10 mg Coming soon
COAs ↓
01ReleasePending independent release
02Latest lotComing soon
03DocumentationCOA pending
04EligibilityQualified laboratory research
01

IDENTITY & SPECIFICATIONS

Exact identity first.

Catalog number
KCC-SET-BT
Material identity
BPC-157 + TB-500 Comparative Research Set
Nominal amount
BPC-157 + TB-500 · 10 mg
Material type
Comparative research set
Set composition
BPC-157 + TB-500
Use classification
Laboratory research use only
LITERATURE REFERENCE

Molecular identity

Published structural information for research review—not measured results, a certificate of analysis, or confirmation of a KCC lot’s identity. Match the exact form to released supplier and lot documentation before use.

Component references only. A blend has no single peptide sequence, molecular formula, molecular weight or CAS number. Ratios, compatibility and combined stability require formulation-specific documentation.

BPC-157

Parent compound; counterions and hydration excluded

Reference sequence / structural notationGEPPPGKPADDAGLV-OH
Backbone residues
15
Reference formula
C62H98N16O22
Reference molecular weight
1419.54 g/mol
Reference CAS
137525-51-0

Linear peptide. Unmarked residues use the L configuration; terminal -OH denotes the free acid.

    TB-500 · acetylated fragment in analytical literature

    Exact catalog form requires confirmation

    Reference fragment; catalog form unresolved

    Reference sequence / structural notationAc-LKKTETQ
    Backbone residues
    7
    Reference formula
    Not assigned in this reference
    Reference molecular weight
    Not assigned in this reference
    Reference CAS
    Not assigned to this form

    The cited study identifies N-acetylated thymosin β4 residues 17–23. The name TB-500 alone does not establish whether a catalog item is this fragment or full-length thymosin β4. No KCC lot sequence, formula, molecular weight or CAS is assigned here.

    How to read the notation

    Sequences run from N to C. Ac = acetyl; -NH2 = C-terminal amide; -OH = free C-terminal acid; D- marks stereochemistry; Aib = α-aminoisobutyric acid; Nle = norleucine; pGlu = pyroglutamate; γ-Glu = gamma-glutamyl linkage; AEEA = 2-[2-(2-aminoethoxy)ethoxy]acetic acid. Lipid linkers and ring closures are described separately. Molecular weights are reference molar masses, not measured MS peaks or per-vial amounts.

    Reference review: September 6, 2026 · Research use only

    02

    RESEARCH CONTEXT

    Research areas & sources.

    Component literature covers BPC-157 fibroblast models and TB-500 analytical characterization.

    This classification is inferred from individual component literature. The linked studies do not establish the performance or safety of this combined set.

    These references explain the research classification. They are not evidence of testing, purity, safety, or efficacy for a KCC Labs product or lot, and do not authorize human or veterinary use.

    03

    AVAILABLE LOTS

    Release-specific status.

    No approved COA is published for this material yet.

    Check this material's current availability and documentation status. Documentation-pending purchases require acknowledgment; an approved COA is published only after release review.

    04

    ANALYTICAL DOCUMENTS

    Evidence tied to the lot.

    No approved analytical document is publicly linked yet.

    A generic certificate is not evidence for this material. Published COAs must correspond to the exact released batch.

    Review the quality framework →
    05

    STORAGE & HANDLING

    Follow the applicable COA and documentation.

    Storage, handling, physical form, and stability conditions may vary by material and lot. Use only the instructions supplied with the released documentation and your institution’s approved laboratory procedures. Do not rely on third-party clinical or administration protocols.

    What the lab record should establish

    Documentation guide—not a claim that these assays have been performed. Only the approved document for the exact lot can establish results. An absent report means no result is published, not that a test passed.

    Identity & structure
    Mass spectrometry / LC–MS and sequence or structural confirmation, as applicable.
    Purity & content
    Lot-specific chromatogram, method and purity result; net compound content reported separately from chromatographic area percentage.
    Chemical form & impurities
    Counterion, hydration, residual solvents and relevant elemental impurities, where characterized.
    Handling & traceability
    Exact lot, SDS, physical form, storage conditions and supported retest or expiry date. Microbiological or endotoxin results only when applicable and documented.